Direct By Syndicate Bio

Direct by Syndicate Bio is redefining access to precision healthcare through science. We bring world-class genetic testing directly to individuals, families, and healthcare providers — empowering people to understand their DNA, make informed decisions, and take proactive steps toward better health. Our suite of tests cover: Hereditary Cancer Testing: Identify inherited mutations linked to breast, ovarian, colorectal, and prostate cancers — enabling early detection, prevention, and family risk assessment. Non-Invasive Prenatal Testing (NIPT): A safe, accurate, and early way to screen for chromosomal conditions in pregnancy using just one blood sample. Somatic Cancer Testing: Analyze tumor DNA to uncover mutations driving cancer growth and guide more targeted, personalized treatment options. Pharmacogenomic Testing: Discover how your genes influence your response to medications and work with your doctor to find the treatments that work best for you. Every Direct test is powered by Syndicate Bio’s deep scientific expertise, global laboratory partnerships, and a commitment to quality that meets international standards. Our genetic reports are actionable insights interpreted by experts. Explore our range of genetic tests and see what your DNA can reveal about your future.